SECURITIES AND EXCHANGE COMMISSION
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported): November 2, 2004
BRISTOL-MYERS SQUIBB COMPANY
|(State or Other
345 Park Avenue
New York, NY, 10154
(Address of Principal Executive Office)
Registrants telephone number, including area code: (212) 546-4000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|o||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|o||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|o||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|o||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
|Item 1.01. Amendment to a Material Definitive Agreement.|
Item 1.01. Amendment to a Material Definitive Agreement.
On November 2, 2004, the vesting of 178,889 shares of restricted stock previously awarded to James Palmer, former Chief Scientific Officer were accelerated pursuant to a decision by the Compensation and Management Development Committee following Dr. Palmers death. In addition, the Compensation and Management Development Committee granted Dr. Palmer full-term participation of Long-Term Performance Awards previously granted to him.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Bristol-Myers Squibb Company|
|Date: November 8, 2004||BY:||/s/ Sandra Leung|
|Name: Sandra Leung|